Loading...
Back to narrative

ALIT: Backlog Momentum Will Drive Margin Expansion Despite Delayed Acceleration

Update shared on 22 Nov 2025

Fair value Decreased 15%
n/a
n/a
AnalystConsensusTarget's Fair Value
n/a
Loading
1Y
-75.2%
7D
-13.2%

Analysts have lowered their price target for Alight from $11.00 to $8.50, citing delayed growth acceleration and reduced profit margins. They note, however, that continued backlog growth supports future margin improvement.

Analyst Commentary

Analysts have shared a range of perspectives following the recent price target adjustment for Alight. Their commentary highlights both encouraging aspects and ongoing challenges for the company.

Bullish Takeaways

  • Bullish analysts emphasize that Alight’s growing backlog is a positive indicator for future revenue streams.
  • There is confidence in the company’s ability to eventually deliver margin expansion, supported by management's outlook.
  • The current Buy rating is maintained by some, which suggests a belief in the company's long-term execution despite near-term obstacles.

Bearish Takeaways

  • Some analysts remain cautious as growth acceleration has been delayed compared to earlier expectations.
  • Profit margins have come under pressure, resulting in a lowered valuation multiple for the stock.
  • Reduced near-term visibility into accelerated performance has prompted a re-evaluation of the company’s valuation.

What's in the News

  • Repurchase of 6,580,136 shares from July to September 2025, completing a total buyback of over 42 million shares for $284.47 million since August 2022 (Buyback Tranche Update).
  • An expanded, multi-year collaboration was announced with IBM to deploy AI solutions. The partnership aims to transform employee benefits and productivity, with pilot deployments expected in early 2026 (Client Announcements).
  • A strategic partnership with MetLife was formed to bring guaranteed income annuities to the Alight Worklife® platform. This will enhance retirement options for more than 12 million defined contribution plan participants (Client Announcements).
  • A limited release of a generative AI-powered benefits enrollment assistant will be available on Alight Worklife® for the 2025 annual enrollment season, providing personalized digital guidance to employees (Product-Related Announcements).
  • Sword Health has been added to the Alight Partner Network, bringing AI-enabled musculoskeletal and behavioral health care solutions to clients with an outcome-based pricing model (Client Announcements).

Valuation Changes

  • Fair Value: Decreased from $6.86 to $5.86. This reflects a lower anticipated intrinsic value per share.
  • Discount Rate: Increased from 9.99 percent to 11.02 percent. This indicates greater perceived risk or uncertainty in future cash flows.
  • Revenue Growth: Declined from 1.49 percent to 1.27 percent. This suggests reduced expectations for near-term expansion.
  • Net Profit Margin: Dropped significantly from 7.01 percent to 1.86 percent, pointing to diminished profitability.
  • Future P/E: Rose sharply from 26.82x to 89.54x. This indicates a higher valuation relative to forward earnings, potentially due to lower projected earnings.

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.